HB 1324 (see companion bill SB 1039) – Maryland

Status: Inactive / Dead
Year Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb1324&stab=01&pid=billpage&tab=subject3&ys=2019RS

Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for certain drug products; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Ac

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found